Skip to main content
OpenTrials

Clinical trial condition

Unresectable Pancreatic Carcinoma

Explore clinical trials studying Unresectable Pancreatic Carcinoma. Study availability and eligibility vary by location and protocol.

16 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Unresectable Pancreatic Carcinoma trial results

Recruiting

Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors

NCT05053971

Conditions
Advanced Malignant Solid Neoplasm, Digestive System Diseases, Digestive System Neoplasms, +14 more
Locations
  • Yale University New Haven, Connecticut, United States
  • UF Health Cancer Institute - Gainesville Gainesville, Florida, United States
  • University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States
View Trial Details
Active, not recruiting

M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

NCT02595931

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Colonic Diseases, +42 more
Locations
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto Palo Alto, California, United States
  • Keck Medical Center of USC Pasadena Pasadena, California, United States
View all 23 locations
View Trial Details
Active, not recruiting

Testing the Safety of the Anti-Cancer Drugs Durvalumab and Olaparib During Radiation Therapy for Locally Advanced Unresectable Pancreatic Cancer

NCT05411094

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +9 more
Locations
  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care Irvine, California, United States
  • Los Angeles General Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
View Trial Details
Active, not recruiting

A Phase 2 Study of Cediranib in Combination With Olaparib in Advanced Solid Tumors

NCT02498613

Conditions
Advanced Malignant Solid Neoplasm, Breast Diseases, Breast Neoplasms, +39 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • UC San Diego Medical Center - Hillcrest San Diego, California, United States
  • UCSF Medical Center-Mount Zion San Francisco, California, United States
View all 16 locations
View Trial Details
Active, not recruiting

Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer

NCT03257761

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +45 more
Locations
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
View Trial Details
Active, not recruiting

A Study in Advanced or Metastatic Gastrointestinal Cancers Exploring Treatment Combinations With Pelareorep and Atezolizumab

NCT07280377

Conditions
Anal Cancer Metastatic, Pancreatic Cancer Metastatic, Squamous Cell Carcinoma of the Anus Stage Unspecified, +1 more
Locations
  • Nationales Centrum für Tumorerkrankungen Heidelberg Heidelberg, Baden-Wurttemberg, Germany
  • SLK-Kliniken Heilbronn GmbH Heilbronn, Baden-Wurttemberg, Germany
  • Universitätsklinikum Tübingen Tübingen, Baden-Wurttemberg, Germany
  • Universitätsklinikum Ulm Ulm, Baden-Wurttemberg, Germany
View all 15 locations
View Trial Details
Active, not recruiting

Gemcitabine Hydrochloride, Paclitaxel Albumin-Stabilized Nanoparticle Formulation, Metformin Hydrochloride, and a Standardized Dietary Supplement in Treating Patients With Pancreatic Cancer That Cannot be Removed by Surgery

NCT02336087

Conditions
Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v6 and v7, Stage IV Pancreatic Cancer AJCC v6 and v7, +1 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • City of Hope Rancho Cucamonga Rancho Cucamonga, California, United States
  • City of Hope South Pasadena South Pasadena, California, United States
  • City of Hope West Covina West Covina, California, United States
View Trial Details
Active, not recruiting

TAS102 in Combination With NAL-IRI in Advanced GI Cancers

NCT03368963

Conditions
Colonic Diseases, Colorectal Adenocarcinoma, Colorectal Neoplasms, +28 more
Locations
  • Emory University Hospital Midtown Atlanta, Georgia, United States
  • Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
  • Emory Saint Joseph's Hospital Atlanta, Georgia, United States
View Trial Details

Related conditions